143 related articles for article (PubMed ID: 37856011)
1. EXOSC2 Mediates the Pro-tumor Role of WTAP in Breast Cancer Cells via Activating the Wnt/β-Catenin Signal.
Lv CG; Cheng Y; Zhang L; Wu GG; Liang CY; Tao Z; Chen B
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37856011
[TBL] [Abstract][Full Text] [Related]
2. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
3. Wilms' Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer.
Xie W; Liu N; Wang X; Wei L; Xie W; Sheng X
Front Oncol; 2021; 11():598344. PubMed ID: 33680959
[TBL] [Abstract][Full Text] [Related]
4. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
Zheng H; Cao Z; Lv Y; Cai X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
[TBL] [Abstract][Full Text] [Related]
5. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.
Ou B; Liu Y; Yang X; Xu X; Yan Y; Zhang J
Cell Death Dis; 2021 Jul; 12(8):737. PubMed ID: 34312368
[TBL] [Abstract][Full Text] [Related]
6. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
Dai X; Chen K; Xie Y
Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
[TBL] [Abstract][Full Text] [Related]
7. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
[TBL] [Abstract][Full Text] [Related]
8. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233
[TBL] [Abstract][Full Text] [Related]
9. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
10. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
Liu N; Zhang C; Zhang L
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37477820
[TBL] [Abstract][Full Text] [Related]
11. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
12. The m
Guo S; Zhao C; Fang L; Xu W; Dalia S; Glass J; Shikama N; Zhang Z
Ann Transl Med; 2022 Jul; 10(14):779. PubMed ID: 35965785
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-β and enhances chemoradiotherapy resistance.
Liu Y; Da M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3977-3988. PubMed ID: 36030434
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
[TBL] [Abstract][Full Text] [Related]
15. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway.
He J; Bu Y; Li X; Zhang X; Ma L
Biol Pharm Bull; 2023; 46(1):74-85. PubMed ID: 36596527
[TBL] [Abstract][Full Text] [Related]
18. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/β-catenin signaling.
Zhou J; Di M; Han H
Onco Targets Ther; 2019; 12():7067-7077. PubMed ID: 31564892
[TBL] [Abstract][Full Text] [Related]
20. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
